{"url_path":"/sec/avx/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1826397/0001493152-26-023348-index.html","accession_number":"0001493152-26-023348","cik":"0001826397","ticker":"AVX","issuer_name":"AVAX ONE TECHNOLOGY LTD.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1826397/0001493152-26-023348-index.html","primary_entity_key":"0001826397","primary_entity_name":"AVAX ONE TECHNOLOGY LTD."},"word_count":240,"has_tables":true,"body_markdown":"**Item\n6. Exhibits**\n\n \n\n31.1\n[Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*](ex31-1.htm)\n\n31.2\n[Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*](ex31-2.htm)\n\n32.1\n[Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*](ex32-1.htm)\n\n32.2\n[Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*](ex32-2.htm)\n\n101.ins\nInline\nXBRL Instance Document\n\n101.sch\nInline\nXBRL Taxonomy Schema Document\n\n101.cal\nInline\nXBRL Taxonomy Calculation Document\n\n101.def\nInline\nXBRL Taxonomy Linkbase Document\n\n101.lab\nInline\nXBRL Taxonomy Label Linkbase Document\n\n101.pre\nInline\nXBRL Taxonomy Presentation Linkbase Document\n\n104\nCover\nPage Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n*\nFiled\nor furnished herewith\n\n \n\nThe\ncertifications furnished in Exhibits 32.1 and 32.2 hereto are deemed to accompany this Quarterly Report on Form 10-Q and are not deemed\n“filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall\nthey be deemed incorporated by reference into any filing under the Securities Act of the Exchange Act.\n\n \n\n34\n\n[Table of Contents](#toc_001)\n\n \n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned, thereunto duly authorized.\n\n \n\n \n**AVAX\nONE TECHNOLOGY LTD.**\n\n \n \n \n\nDate:\nMay 15, 2026\nBy:\n*/s/\nJolie Kahn*\n\n \n \nJolie\nKahn\n\n \n \nChief\nExecutive Officer (Principal Executive Officer)\n\n \n \n \n\nDate:\nMay 15, 2026\nBy:\n*/s/\nChris Polimeni*\n\n \n \nChris\nPolimeni\n\n \n \nChief\nFinancial Officer (Principal Financial and Accounting Officer)\n\n \n\n35"}